Home › Trial NCT02121899
Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)
- Trial IDNCT02121899
- StatusTerminated
- PhaseN/A
- Study typeObservational
- SponsorMyriad Genetic Laboratories, Inc.
- Enrollment44
- Start date2015-04
- ConditionsLung Cancer · NSCLC · NSCLC Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.